She worked to develop a regional network for referral of patients maintaining a multidisciplinary team that serves as second opinion for non-academic centres. She is also very active in leading the initiatives of the Patients’ organization from Padova, such as IPF World Week and psychologic support for patients. Her main research interests include interstitial lung disease and in particular Idiopathic Pulmonary Fibrosis.
rare lung diseases and in interstitial lung disease, particularly on genetic
cause of pulmonary fibrosis.
Department of Rheumatology, University Hospital Zurich and Balgrist
University Hospital in Zurich, Switzerland. Since 2018, he is Head of the
Business Division, Traumatology-Dermatology-Rheumatology-Plastic
Surgery and Emergency Medicine (TDR), at the University Hospital Zurich
and Board Member at the Faculty of Medicine at the University of Zurich.
Next to his clinical work at the outpatient and inpatient clinic in the field of
Rheumatology, he is regularly involved in teaching activities and speaker at
international conferences and further educations. In addition, he is Co-
Founder of multiple international networks and training programs, e.g.
EUSTAR (European Scleroderma Trials and Research Group), World
Scleroderma Congress, JSRD (Journal of scleroderma and related diseases),
Educational Masterclass series on SSc-ILD.
He is a member of the Irish Thoracic Society Interstitial Lung Disease Registry Steering Committee and of the Institute of Directors in Ireland. He was previously General Manager/Head of Medical Affairs at the Ireland affiliate of Boehringer Ingelheim.
Colin is driven by curiosity and interested in exploring how new technologies can improve the understanding of medical conditions and their impact on peoples’ lives.
Department of Pneumonology and Allergology at the University Hospital in
Gdańsk, Poland. She is a co-author of 257 publications (Web of Science
database, viewed Oct. 2019), mainly on lung cancer, asthma, COPD and
mastocytosis. She is also the editor of four books on pneumonology and
the author of 25 book chapters. She is a member of the Polish Respiratory
Society executive board and has contributed to the development of
numerous treatment guidelines – among others in IPF, COPD and palliative
care in chronic respiratory diseases. She is also an initiator and coordinator
of the regional program of integrated care in patients with advanced
Pulmonary Fibrosis for eight years but was fortunate to receive a lung transplant in 2016.
During his professional life, he worked as an adviser to the European Union, World Bank and other agencies on development programmes in Asia and Africa. He is a European Idiopathic Pulmonary Fibrosis and Related Disorders Federation (EU-IPFF) Executive Board Member and is a member of the Council of the European Lung Foundation.
is still professionally active. He is one of the founding members of the
Polish Society for Supporting Patients with Idiopathic Pulmonary
Fibrosis and actively cooperates with people affected by IPF.
Since then he has been active within the various patient organisations. In 2016 he founded the Lung Fibrosis Forum Austria together with other patients. As a Chairman, Mr. Wanke represents the ILD patients and supports their needs and rights in the healthcare system. A particular concern for him is to advocate for more research, rapid diagnosis and the best treatment options. Finally, Mr. Wanke tries everything to find a treatment that heals IPF.